JPH06130060A - Method for increasing specific gravity of particles for particle immunoassay - Google Patents

Method for increasing specific gravity of particles for particle immunoassay

Info

Publication number
JPH06130060A
JPH06130060A JP16471292A JP16471292A JPH06130060A JP H06130060 A JPH06130060 A JP H06130060A JP 16471292 A JP16471292 A JP 16471292A JP 16471292 A JP16471292 A JP 16471292A JP H06130060 A JPH06130060 A JP H06130060A
Authority
JP
Japan
Prior art keywords
specific gravity
carrier
particles
artificial
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP16471292A
Other languages
Japanese (ja)
Inventor
Kazufumi Yagyu
一史 柳生
Makoto Iwatsuki
誠 岩月
Yoshitaka Imagawa
義孝 今川
Takenori Hirai
武徳 平井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Ajinomoto Co Inc
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc, Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Ajinomoto Co Inc
Priority to JP16471292A priority Critical patent/JPH06130060A/en
Publication of JPH06130060A publication Critical patent/JPH06130060A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

(57)【要約】 【構成】 動物赤血球や人工担体などの粒子免疫測定用
粒子を金属塩溶液で処理することにより高比重化粒子を
作製する。 【効果】 本発明で得られる高比重化粒子をマイクロプ
レート凝集反応法の如き測定法に用いると、従来の粒子
免疫測定用粒子と比較して、より短時間の判定が可能と
なる。
(57) [Summary] [Structure] Particles for immunoassay, such as animal red blood cells and artificial carriers, are treated with a metal salt solution to prepare high specific gravity particles. [Effects] When the highly-densified particles obtained in the present invention are used in a measurement method such as a microplate agglutination reaction method, it is possible to make a determination in a shorter time than conventional particles for particle immunoassay.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は免疫学的検査、特に、粒
子免疫測定法における担体の高比重化法、並びにそのよ
うな粒子を用いて判定時間を短縮した免疫学的検査試薬
に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an immunological test, and more particularly to a method for increasing the specific gravity of a carrier in a particle immunoassay, and an immunological test reagent using such particles to shorten the determination time.

【0002】[0002]

【従来技術および問題点】疾病の診断においては、検査
対象の生体成分が微量であるために、一般には抗原抗体
反応を利用した免疫血清学的検査法が利用されてきた。
この検査法の最大の特徴は、体液中及び尿中に分泌され
る生体成分を極めて高い感度と特異性をもって測定でき
る点にある。このような検査法の一つに粒子免疫測定法
がある。一般に、粒子免疫測定法においては、適当な大
きさの粒子を担体とし、これに抗原または抗体を感作
(吸着または結合)させ、それぞれに対応する抗体また
は抗原の存在によってこの感作された担体が凝集を生ず
ることを原理としている。従来、上記粒子免疫測定法に
おいて最も一般的に使用されている担体粒子としては、
例えば、ヒツジまたはニワトリのような各種動物の赤血
球、またはポリスチレンラテックス粒子のような人工的
に合成された高分子粒子とがある。前者の動物血球を担
体として用いる方法はいわゆる血球凝集反応として古く
から行なわれており、この方法は対象とされ得る抗原及
び抗体の範囲が広く、マイクロタイター法を利用すると
2〜3時間のうちに判定を行なうことができるという点
では優れた物である。さらにまた、血球の大きさが動物
の種類によりそれぞれ一定しているという利点がある。
2. Description of the Related Art In diagnosing a disease, an immunoserologic test method utilizing an antigen-antibody reaction has been generally used because the amount of biological components to be tested is minute.
The greatest feature of this test method is that biological components secreted in body fluids and urine can be measured with extremely high sensitivity and specificity. One of such inspection methods is a particle immunoassay method. Generally, in the particle immunoassay, particles of an appropriate size are used as carriers, and antigens or antibodies are sensitized (adsorbed or bound) to the carriers, and the carriers sensitized by the presence of the corresponding antibodies or antigens, respectively. Is caused by aggregation. Conventionally, the carrier particles most commonly used in the above-mentioned particle immunoassay method include:
For example, erythrocytes of various animals such as sheep or chicken, or artificially synthesized polymer particles such as polystyrene latex particles. The former method using animal blood cells as a carrier has been performed as a so-called hemagglutination reaction for a long time, and this method has a wide range of antigens and antibodies that can be targeted, and when the microtiter method is used, it takes only 2-3 hours. It is an excellent item in that it can make a judgment. Furthermore, there is an advantage that the size of blood cells is constant depending on the type of animal.

【0003】一方、従来からのポリスチレン等の合成高
分子粒子は、一般に0.1〜1μm 程度の粒径を有し、特
にラテックス凝集反応用の担体として有用であり、それ
自体が抗原性を有しない点及び均質のものを大量に安定
して入手し得る点で優れている。さらに、最近、ゼラチ
ン、水溶性多糖類及びポリメタリン酸ナトリウムを含
み、アルデヒド系架橋剤により架橋された不溶化粒状人
工担体(特開昭57-153658号、特開昭57-160465号等)、
いわゆるゼラチン担体粒子及びポリアミノ酸を主原料と
したポリアミノ酸人工担体(特開平2-103470)が開発さ
れ、動物血球に代るものとして実用化され使用されてい
る。これらの人工担体は、免疫凝集反応用の担体として
は従来最も優れているとされていた動物赤血球と同等な
性能を有し、さらに化学的、物理的に均質かつ安定であ
り、抗原活性がなく任意の粒径のものを容易に大量生産
できるという利点を有する。しかしながら、従来の合成
高分子物質より成る粒子(例えばポスチレンラテックス
粒子)は、高い感度を得ると共に定量的な判定を行なう
ためにマイクロタイター法を利用すると、血球を担体と
して用いる場合に比して、沈降に長時間を必要とし、迅
速な判定を行なうことができない問題がある。また、動
物赤血球やゼラチン担体を用いた場合、2〜3時間と比
較的短時間で判定が可能ではあるが、最近の臨床検査の
分野における測定の迅速化及び自動化傾向に伴い、凝集
反応検査においても、さらに迅速な判定時間が望まれる
ようになった。
On the other hand, conventional synthetic polymer particles such as polystyrene generally have a particle size of about 0.1 to 1 μm and are particularly useful as a carrier for a latex agglutination reaction, and have an antigenicity themselves. It is excellent in that it does not do so and that it can stably obtain a large amount of homogeneous products. Furthermore, recently, an insolubilized granular artificial carrier containing gelatin, a water-soluble polysaccharide and sodium polymetaphosphate and cross-linked with an aldehyde cross-linking agent (JP-A-57-153658, JP-A-57-160465, etc.),
So-called gelatin carrier particles and a polyamino acid artificial carrier mainly composed of polyamino acid have been developed and put to practical use as a substitute for animal blood cells. These artificial carriers have the same performance as animal erythrocytes, which were previously considered to be the best as carriers for immunoaggregation reactions, are chemically and physically homogeneous and stable, and have no antigenic activity. It has the advantage that it can easily be mass-produced with any particle size. However, particles made of conventional synthetic polymer substances (for example, polystyrene particles) have higher sensitivity and use the microtiter method for quantitative determination, compared with the case where blood cells are used as a carrier. However, there is a problem that it takes a long time for sedimentation, and quick determination cannot be performed. In addition, when using animal red blood cells or gelatin carriers, it is possible to make a determination in a relatively short time of 2-3 hours, but with the recent trend toward rapid and automated measurement in the field of clinical testing, agglutination test However, a quicker determination time has come to be desired.

【0004】判定時間を短縮するためには、使用する担
体の沈降速度を上げることが考えられる。沈降速度を上
げる一つの手段として、担体の粒径を増大させることが
ある。しかしながら、担体の粒径を増大させると、トー
タルの表面積が減少する結果、抗原または抗体の固定化
量を減少させることになり、適切な手段とは言い難い。
沈降速度を上げるもう一つの手段として、比重の大きい
担体、あるいは高比重化した担体を使用することが考え
られる。この方法であれば、トータルの表面積を減少さ
せることなく、沈降速度を上げることが可能である。し
かしながら、比重の大きい担体を作製するには、それを
作製するための原料から検討する必要があり、比重の大
きい担体が得られたとしても、それが従来より用いられ
ている粒子免疫測定用担体と比較して、測定系において
同等かそれ以上の感度を与えうる性質を有するかどうか
の問題が残る。一方、従来より使用されている担体を高
比重化する場合、それらの担体の有する特性を損なうこ
となく、簡便に高比重化できれば最も好ましい。なお、
絹についてはスズ塩を用いて増量する方法が知られては
いたが(坂口育三、(「続・絹糸の構造」北条ら編、信
州大学繊維学部発行)、p586-624(1980年))、今日ま
でこのような担体を高比重化した例は一切報告されてい
ない。
In order to shorten the determination time, it is possible to increase the sedimentation rate of the carrier used. One way to increase the sedimentation rate is to increase the particle size of the carrier. However, increasing the particle size of the carrier results in a decrease in the total surface area, resulting in a decrease in the immobilized amount of the antigen or antibody, which cannot be said to be an appropriate means.
As another means for increasing the sedimentation speed, it is possible to use a carrier having a large specific gravity or a carrier having a high specific gravity. With this method, the sedimentation rate can be increased without reducing the total surface area. However, in order to produce a carrier with a large specific gravity, it is necessary to study from the raw materials for producing it, and even if a carrier with a large specific gravity is obtained, it is a carrier for particle immunoassay that has been conventionally used. In comparison with, there remains a question of whether or not the measurement system has the property of giving equal or higher sensitivity. On the other hand, in the case of increasing the specific gravity of the conventionally used carriers, it is most preferable that the specific gravity can be easily increased without impairing the characteristics of those carriers. In addition,
Although there was a known method for increasing the amount of silk by using tin salt (Ikuzo Sakaguchi, (Continued: Silk Structure, edited by Hojo et al., Published by Shinshu University, Faculty of Textile Science), p586-624 (1980)) Until now, no examples have been reported in which such a carrier has a high specific gravity.

【0005】[0005]

【問題を解決するための手段】これらの問題を鑑み、本
発明者らは鋭意研究を重ねた結果、前述した如き従来の
粒子免疫測定用粒子を簡便に高比重化する方法を見い出
した。すなわち、動物赤血球や人工担体を金属塩溶液で
処理することにより、容易に比重を高めることができ、
その結果、マイクロプレート凝集反応法の如き測定法に
おいて、より短時間で判定できるような担体を作製する
ことに成功した。すなわち、本発明は、粒子を金属塩溶
液で処理することを特徴とする粒子免疫測定用粒子の高
比重化法を提供する。又、このようにして高比重化され
た粒子免疫測定用粒子からなる検査試薬を提供する。本
発明において高比重化を行なう粒子には、従来より粒子
免疫測定用粒子として用いられているヒツジまたはニワ
トリのような各種動物の赤血球、またはポリスチレンラ
テックス粒子、ゼラチン担体、ポリアミノ酸担体などの
ような人工担体のいずれも使用可能である。本発明の高
比重化は、動物赤血球や人工担体を金属塩水溶液で攪拌
処理し、その後緩衝液で加熱処理することにより行なわ
れる。金属塩としては、スズ、鉛、カルシウム、マグネ
シウム、亜鉛等の塩、例えば、塩酸塩、硫酸塩、硝酸
塩、酢酸塩、塩化物などが用いられる。具体的には、塩
化第二スズ、アルミニウム硫酸塩、アルミニウム酢酸
塩、塩化アルミニウム、チタン硫酸塩、チタン酢酸塩、
塩化チタン、ストロンチウム硫酸塩、塩化ストロンチウ
ム等があげられ、なかでも塩化第二スズのようなスズ塩
が有効である。
In view of these problems, the present inventors have conducted intensive studies and, as a result, have found a method for easily increasing the specific gravity of conventional particles for immunoassay as described above. That is, by treating animal red blood cells and artificial carriers with a metal salt solution, the specific gravity can be easily increased,
As a result, we succeeded in producing a carrier that can be determined in a shorter time in a measurement method such as the microplate agglutination reaction method. That is, the present invention provides a method for increasing the specific gravity of particles for particle immunoassay, which comprises treating the particles with a metal salt solution. Also provided is a test reagent comprising particles for immunoassay having a high specific gravity in this manner. In the present invention, particles having a high specific gravity include red blood cells of various animals such as sheep or chicken which have been conventionally used as particles for particle immunoassay, or polystyrene latex particles, gelatin carrier, polyamino acid carrier, etc. Any of the artificial carriers can be used. The high specific gravity of the present invention is carried out by subjecting animal red blood cells and artificial carriers to stirring treatment with an aqueous metal salt solution, and then heat treating with a buffer solution. As the metal salt, salts of tin, lead, calcium, magnesium, zinc and the like, for example, hydrochlorides, sulfates, nitrates, acetates, chlorides and the like are used. Specifically, stannic chloride, aluminum sulfate, aluminum acetate, aluminum chloride, titanium sulfate, titanium acetate,
Examples thereof include titanium chloride, strontium sulfate, and strontium chloride. Among them, tin salts such as stannic chloride are effective.

【0006】本発明の高比重化に用いられる金属塩は通
常20〜60w/w %水溶液で用いるのがよい。20w/w %以下
では、処理に長時間を要し、60w/w %以上では操作性が
低下する。用いる金属塩の量は、通常担体の5倍重量以
上とするのがよい。処理時間は、担体の種類、量によっ
て異なるが通常30分から2時間程度である。処理温度
は、10〜70°C の範囲で可能であるが、通常室温、即ち
15〜25°C で行なわれる。上記、金属塩処理後、担体を
分離し、緩衝液で処理する。用いる緩衝液は通常pH6
から8程度のリン酸緩衝溶液が用いられる。また、通常
用いられる他の緩衝液、例えばクエン酸、酢酸、ホウ酸
緩衝液も使用可能である。処理温度は 20〜90°C であ
り、好ましくは50〜80℃であり、処理時間は15分から2
時間程度である。緩衝液処理後は、フィルタ−濾過、遠
心分離、デカンテ−ション等の分離操作により高比重化
された担体を得ることができる。本発明によって調製し
た粒子に対して抗原または抗体を感作するには、従来の
動物赤血球に対する感作法を用いて容易に行なう事が出
来る。例えば、得られた担体粒子を常法によりタンニン
酸処理した後、目的の抗原または抗体を吸着させる。感
作させる抗原または抗体としては、測定すべき抗原また
は抗体に対応する天然由来または遺伝子組換え、細胞融
合、化学合成等の人為的手段に由来する任意のものであ
り得る。
The metal salt used for increasing the specific gravity of the present invention is usually used in a 20 to 60 w / w% aqueous solution. When it is 20 w / w% or less, it takes a long time to process, and when it is 60 w / w% or more, the operability is deteriorated. The amount of the metal salt used is usually 5 times the weight of the carrier or more. The treatment time varies depending on the type and amount of carrier, but is usually about 30 minutes to 2 hours. The treatment temperature can be in the range of 10 to 70 ° C, but usually room temperature, that is,
It is carried out at 15-25 ° C. After the above metal salt treatment, the carrier is separated and treated with a buffer solution. The buffer used is usually pH 6
A phosphate buffer solution of about 8 to 8 is used. Also, other commonly used buffers such as citric acid, acetic acid, borate buffers can be used. The treatment temperature is 20 to 90 ° C, preferably 50 to 80 ° C, and the treatment time is 15 minutes to 2
It's about time. After the buffer solution treatment, a carrier having a high specific gravity can be obtained by a separation operation such as filter-filtration, centrifugation, decantation and the like. To sensitize the particles prepared according to the present invention with an antigen or an antibody, conventional sensitization methods for animal red blood cells can be easily used. For example, the obtained carrier particles are treated with tannic acid by a conventional method, and then the target antigen or antibody is adsorbed. The antigen or antibody to be sensitized may be any one derived from a natural source corresponding to the antigen or antibody to be measured or derived from an artificial means such as gene recombination, cell fusion, chemical synthesis or the like.

【0007】[0007]

【発明の効果】本発明によれば、従来の粒子免疫測定法
に用いられる担体を非常に簡便に高比重化することが可
能である。また、得られた感作担体は、以下の実施例で
示すとおり、従来の動物血球あるいは人工担体と比較し
て、沈降速度が速いこと、すなわち、判定時間の短縮が
可能であり、かつ、判定時の力価も損なわないという大
きな利点を有している。以下、本発明及びその特徴を実
施例により具体的に説明する。
EFFECTS OF THE INVENTION According to the present invention, it is possible to very simply and easily increase the specific gravity of the carrier used in the conventional particle immunoassay. Further, the obtained sensitized carrier, as shown in the following examples, that the sedimentation rate is faster, that is, the judgment time can be shortened, and the judgment can be made, as compared with conventional animal blood cells or artificial carriers. It has the great advantage of not compromising the strength of time. Hereinafter, the present invention and its features will be specifically described with reference to examples.

【0008】[0008]

【実施例】【Example】

実施例1高比重化人工担体の作製 塩化第二スズ5水塩(和光純薬製)22.6gに水34.12gを
加え攪拌溶解し、塩化第二スズ水溶液を調製した。特開
平2-103470記載の方法により得られたポリアミノ酸人工
担体(サンプル1)の懸濁水溶液30ml(担体含有量12.5
v/v %)をグラスフィルタ−(No.4)を用いて担体を分
離した後、塩化第二スズ水溶液3mlで洗浄した。更に塩
化第二スズ水溶液15mlを加え、25°C で60分間攪拌し
た。終了後グラスフィルタ−(No.4)で担体を分離した
後、リン酸緩衝溶液(Na濃度=0.2mol/l,pH=7.5 )50
mlを加え液温60〜65℃で30分間攪拌、加熱した。終了後
デカンテ−ションで人工担体を分離し、生理食塩水を用
い、遠心沈降(700 〜3000rpm 、3〜5分間)を4、5
回繰り返して洗浄した。最後に、生理食塩水約50mlを加
え、5°C で一夜放置した後、超音波処理で担体表面の
余分な金属塩を除去し、担体を分散させた後、デカンテ
−ションで生理食塩水を分離し、更に生理食塩水を加
え、高比重化人工担体懸濁液50mlを得た(サンプル
2)。担体含有量は7.5v/v%であった。
Example 1 Preparation of artificial carrier with high specific gravity 34.12 g of water was added to 22.6 g of stannic chloride pentahydrate (manufactured by Wako Pure Chemical Industries, Ltd.) and dissolved by stirring to prepare an aqueous stannic chloride solution. 30 ml of an aqueous suspension of a polyamino acid artificial carrier (Sample 1) obtained by the method described in JP-A-2-103470 (carrier content 12.5
The carrier (v / v%) was separated using a glass filter (No. 4) and then washed with 3 ml of an aqueous stannic chloride solution. Further, 15 ml of an aqueous stannic chloride solution was added, and the mixture was stirred at 25 ° C for 60 minutes. After completion, after separating the carrier with a glass filter (No.4), phosphate buffer solution (Na concentration = 0.2 mol / l, pH = 7.5) 50
ml was added, and the mixture was stirred and heated at a liquid temperature of 60 to 65 ° C for 30 minutes. After the completion, the artificial carrier was separated by decantation, and a physiological saline solution was used to perform centrifugal sedimentation (700 to 3000 rpm, 3 to 5 minutes) for 4, 5
Repeatedly washed. Finally, add about 50 ml of physiological saline, leave it at 5 ° C overnight, remove excess metal salt on the surface of the carrier by sonication, disperse the carrier, and decant the saline. After separation, physiological saline was further added to obtain 50 ml of a highly specific gravity artificial carrier suspension (Sample 2). The carrier content was 7.5 v / v%.

【0009】実施例2高比重化羊血球の作製 羊赤血球(サンプル3)を10v/v %含有する懸濁水溶液
30mlを用い、実施例1と同様の処理を行なって、高比重
化処理血球懸濁液50mlを得た(サンプル4)。担体含有
量は6v/v%であった。 実施例3比重測定 塩化セシウム密度勾配遠心平衡法により担体の比重を測
定した。塩化セシウム(片山化学工業 密度勾配遠心用
塩化セシウム)水溶液10mlを遠心チュ−ブに小分けし、
1v/v %担体分散液を0.2ml重層し、遠心操作を行なっ
た(遠心機:日立70P-72,ロ−タ:日立RPS40T,回転
数:30,000 rpm,遠心時間:72時間)。遠心後、サンプ
ル担体が浮遊している部分を採取し、リフラクトメ−タ
(ATAGO Model 3 )で屈折率を測定し、比重を数
式1により求めた。各種担体の比重測定結果を表1に示
した。
Example 2 Preparation of highly specific density sheep blood cells A suspension aqueous solution containing 10 v / v% sheep red blood cells (sample 3)
The same treatment as in Example 1 was carried out using 30 ml to obtain 50 ml of a hyperspecific gravity-treated blood cell suspension (sample 4). The carrier content was 6 v / v%. Example 3 Specific gravity measurement The specific gravity of the carrier was measured by a cesium chloride density gradient centrifugal equilibrium method. Divide 10 ml of cesium chloride (Katayama Chemical Industry cesium chloride for density gradient centrifugation) aqueous solution into centrifuge tubes,
0.2 ml of a 1 v / v% carrier dispersion was layered and centrifuged (centrifuge: Hitachi 70P-72, rotor: Hitachi RPS40T, rotation speed: 30,000 rpm, centrifugation time: 72 hours). After centrifugation, the part in which the sample carrier was suspended was collected, the refractive index was measured with a refractometer (ATAGO Model 3), and the specific gravity was calculated by the mathematical formula 1. Table 1 shows the specific gravity measurement results of various carriers.

【数式1】 比重=屈折率×10.2402-12.6483[Formula 1] Specific gravity = Refractive index × 10.2402-12.6483

【0010】[0010]

【表1】 表1 塩化セシウム 屈折率 比重 水溶液濃度 未処理 人工担体 50w/w% 1.3753 1.4350 (サンプル1) 高比重化 人工担体 52.4w/w% 1.3928 1.6143 (サンプル2) 未処理血球 40w/w% 1.3619 1.2978 (サンプル3) 高比重化処理 血球 50w/w% 1.3867 1.5518 (サンプル4) [Table 1] Table 1 Cesium chloride Refractive index Specific gravity aqueous solution concentration Untreated artificial carrier 50w / w% 1.3753 1.4350 (Sample 1) High specific gravity artificial carrier 52.4w / w% 1.3928 1.6143 (Sample 2) Untreated blood cells 40w / w% 1.3619 1.2978 (Sample 3) High specific gravity blood cells 50w / w% 1.3867 1.5518 (Sample 4)

【0011】実施例4感作方法 下記の表2で示す各々の感作材料(抗原または抗体)を
実施例1で調製した本発明により得られた高比重化担体
(サンプル2)および参照として未処理ポリアミノ酸担
体(サンプル1)を、常法に従いタンニン酸感作した。
検体としては、各々の感作抗原、抗体に対応したヒト陽
性血清およびヒト陰性血清を用いた。例えば、HBs 抗原
感作担体についての試験の場合は、陽性検体としてHBs
抗体陽性ヒト血清を用い、陰性検体としてはHBs抗体陰
性ヒト血清を用いた。但し、牛血清アルブミン(BSA )
感作担体については、抗BSAウサギ免疫血清を陽性検体
とした。なお、感作条件は次のようであった。まず、PB
S(pH7.2)中2.5v/v%担体と、同じくPBS 中8万倍希釈タ
ンニン酸を各々1容づつ混合し、37℃で約30分間処理し
て遠心分離し、PBS で洗浄した。次いで、得られたタン
ニン酸処理担体2.5v/v%PBS浮遊液1容と各感作材料の1
0μg /ml液1容とを混合し、37℃、30分間処理して遠
心分離を行ないPBS で洗浄し、1v/v %の濃度となるよ
うに保存用メジウム中に浮遊させた。マイクロタイター法凝集反応試験 得られた感作担体を用いて、担体凝集反応試験を通常の
マイクロタイター法により実施した。まず、マイクロタ
イタープレートに所定の希釈液25μlずつ滴下し、次い
で第一ウェルに検体25μl をとり、2倍段階希釈を行な
う。次に、各々の感作担体浮遊液(1v/v%)を25μl ず
つ滴下し、良く混和させたのち室温に静置させ、凝集を
示した最高の検体希釈倍数をもって凝集価(力価)とし
た。結果は下記の表2のとおりであり、本発明により得
られた担体は未処理担体と同等の力価を示した。
Example 4 Sensitization Method Each of the sensitizing materials (antigen or antibody) shown in Table 2 below was prepared in Example 1 and the high specific gravity carrier (Sample 2) obtained according to the present invention and not yet used as a reference. The treated polyamino acid carrier (Sample 1) was sensitized with tannic acid according to a conventional method.
Human positive sera and human negative sera corresponding to each sensitizing antigen and antibody were used as samples. For example, in the case of the test for HBs antigen-sensitized carrier, HBs
Antibody-positive human serum was used, and HBs antibody-negative human serum was used as a negative sample. However, bovine serum albumin (BSA)
As a sensitizing carrier, anti-BSA rabbit immune serum was used as a positive sample. The sensitization conditions were as follows. First, PB
2.5 v / v% carrier in S (pH 7.2) and 1 volume of 80,000-fold diluted tannic acid in PBS were mixed, treated at 37 ° C. for about 30 minutes, centrifuged, and washed with PBS. Then, 1 volume of the obtained tannic acid-treated carrier 2.5 v / v% PBS suspension and 1 of each sensitizing material
The mixture was mixed with 1 volume of 0 μg / ml solution, treated at 37 ° C. for 30 minutes, centrifuged, washed with PBS, and suspended in a storage medium at a concentration of 1 v / v%. Microtiter method agglutination test A carrier agglutination test was carried out by the usual microtiter method using the obtained sensitized carrier. First, 25 μl each of a predetermined dilution is dropped onto a microtiter plate, and then 25 μl of a sample is placed in the first well to perform 2-fold serial dilution. Next, 25 μl of each sensitized carrier suspension (1 v / v%) was added dropwise, mixed well, and allowed to stand at room temperature. did. The results are shown in Table 2 below, and the carrier obtained according to the present invention showed a titer equivalent to that of the untreated carrier.

【0012】[0012]

【表2】 表2 力価 感作材料 陽性検体 陰性検体 HBc抗原 サンプル1に感作 291 (組換え酵母 由来) サンプル2に感作 291 HBs抗原 サンプル1に感作 271 (プラズマ由来) サンプル2に感作 261 HBs抗原 サンプル1に感作 271 (組換え酵母 由来) サンプル2に感作 271 HBs抗体 サンプル1に感作 281 (モルモット) サンプル2に感作 281 BSA サンプル1に感作 291 サンプル2に感作 291 [Table 2] Table 2 Potency Sensitization Material Positive Specimen Negative Specimen HBc Antigen Sensitized to Sample 2 9 2 1 (from recombinant yeast ) Sensitized to Sample 2 9 2 1 HBs antigen Sensitized to Sample 1 2 7 2 1 (derived from plasma) Sample 2 sensitized 2 6 2 1 HBs antigen Sample 1 sensitized 2 7 2 1 (from recombinant yeast ) Sample 2 sensitized 2 7 2 1 HBs antibody Sample 1 sensitized 2 8 2 1 (guinea pig) Sample Sensitization to 2 2 8 2 1 BSA Sensitization to sample 1 2 9 2 1 Sensitization to sample 2 2 9 2 1

【0013】実施例5判定時間の測定 マイクロタイタープレートに所定の希釈液25μl ずつ滴
下し、次に、各々の感作ポリアミノ酸担体浮遊液(1v/v
%)を25μl ずつ滴下し、良く混和させたのち室温に静
置させ、その陰性像の直径(mm)を時間毎に測定した結
果を表3に示した。
Example 5 Determination of Judgment Time 25 μl of a predetermined dilution was dropped on a microtiter plate, and then each sensitized polyamino acid carrier suspension (1 v / v) was added.
%), And the mixture was allowed to stand at room temperature, and the diameter (mm) of the negative image thereof was measured every hour. The results are shown in Table 3.

【0014】[0014]

【表3】 表3 時間 BSA感作 BSA感作 HBC 抗原感作 HBC 抗原感作 未処理担体 高比重化担体 未処理担体 高比重化担体 (分) (mm) (mm) (mm) (mm) 10 測定不可能 0.33 測定不可能 0.33 20 測定不可能 0.50 測定不可能 0.50 30 0.33 0.66 0.33 0.65 40 0.50 0.83 0.50 0.81 50 0.67 0.92 0.66 0.90 60 0.81 1.00 0.81 0.98 90 0.92 1.00 0.92 0.98 120 1.00 1.00 1.00 0.98 900 1.03 1.02 1.02 0.99 [Table 3] Table 3 Time BSA sensitization BSA sensitization HB C antigen sensitization HB C antigen sensitization Untreated carrier High specific gravity carrier Untreated carrier High specific gravity carrier (min) (mm) (mm) (mm) (mm) 10 Not measurable 0.33 Not measurable 0.33 20 Not measurable 0.50 Not measurable 0.50 30 0.33 0.66 0.33 0.65 40 0.50 0.83 0.50 0.81 50 0.67 0.92 0.66 0.90 60 0.81 1.00 0.81 0.98 090 0.92 1.00 0.92 0.98 120 1.00 1.00 1.00 0.98 900 1.03 1.02 1.02 0.99

【0015】一般に、マイクロタイター法による陰性検
体の判定には、充分な時間放置後得られた陰性像の直径
(通常約1mm)に対して80%以上の陰性像が得られれば
判定可能である。従って、充分な判定を行なうのに未処
理担体は約60〜90分を要したのに対し、本発明の担体は
約40〜60分で判定可能であった。
In general, the determination of a negative sample by the microtiter method can be performed if a negative image of 80% or more is obtained with respect to the diameter (usually about 1 mm) of the negative image obtained after leaving for a sufficient time. . Therefore, it took about 40 to 60 minutes for the carrier of the present invention, whereas the untreated carrier required about 60 to 90 minutes to make a sufficient judgment.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 今川 義孝 熊本県熊本市東町4丁目16番 2−205号 (72)発明者 平井 武徳 熊本県菊池郡西合志町須屋2080−10 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Yoshitaka Imagawa 4-16-2205, Higashimachi, Kumamoto City, Kumamoto Prefecture (72) Inventor Takenori Hirai 2080-10 Suya, Nishigoshi Town, Kikuchi District, Kumamoto Prefecture

Claims (9)

【特許請求の範囲】[Claims] 【請求項1】 粒子を金属塩溶液で処理することを特徴
とする粒子免疫測定用粒子の高比重化法。
1. A method for increasing the specific gravity of particles for immunoassay of particles, which comprises treating the particles with a metal salt solution.
【請求項2】 金属塩溶液が塩化第二スズ溶液である請
求項1記載の高比重化法。
2. The method of increasing specific gravity according to claim 1, wherein the metal salt solution is a stannic chloride solution.
【請求項3】 塩化第二スズ溶液の濃度が20〜60w/
w%である請求項2記載の高比重化法。
3. The concentration of the stannic chloride solution is 20-60 w /
The high specific gravity method according to claim 2, wherein w is w%.
【請求項4】 粒子が人工担体である請求項1記載の高
比重化法。
4. The method of increasing specific gravity according to claim 1, wherein the particles are artificial carriers.
【請求項5】 人工担体がポリアミノ酸担体である請求
項4記載の高比重化法。
5. The method of increasing specific gravity according to claim 4, wherein the artificial carrier is a polyamino acid carrier.
【請求項6】 人工担体がポリスチレンラテックス粒子
である請求項4記載の高比重化法。
6. The method of increasing specific gravity according to claim 4, wherein the artificial carrier is polystyrene latex particles.
【請求項7】 人工担体がゼラチン担体である請求項4
記載の高比重化法。
7. The artificial carrier is a gelatin carrier.
High specific gravity method described.
【請求項8】 粒子が動物赤血球である請求項1記載の
高比重化法。
8. The method of increasing specific gravity according to claim 1, wherein the particles are animal red blood cells.
【請求項9】 請求項1から8のいずれか1項記載の高
比重化法により得られる粒子免疫測定用粒子からなる検
査試薬。
9. A test reagent comprising particles for particle immunoassay obtained by the method of increasing specific gravity according to any one of claims 1 to 8.
JP16471292A 1992-06-23 1992-06-23 Method for increasing specific gravity of particles for particle immunoassay Withdrawn JPH06130060A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16471292A JPH06130060A (en) 1992-06-23 1992-06-23 Method for increasing specific gravity of particles for particle immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16471292A JPH06130060A (en) 1992-06-23 1992-06-23 Method for increasing specific gravity of particles for particle immunoassay

Publications (1)

Publication Number Publication Date
JPH06130060A true JPH06130060A (en) 1994-05-13

Family

ID=15798457

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16471292A Withdrawn JPH06130060A (en) 1992-06-23 1992-06-23 Method for increasing specific gravity of particles for particle immunoassay

Country Status (1)

Country Link
JP (1) JPH06130060A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007126151A1 (en) * 2006-04-28 2007-11-08 Hitachi Maxell, Ltd. Functional particle, and method for separation of target substance using the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007126151A1 (en) * 2006-04-28 2007-11-08 Hitachi Maxell, Ltd. Functional particle, and method for separation of target substance using the same
JPWO2007126151A1 (en) * 2006-04-28 2009-09-17 日立マクセル株式会社 Functional particle and method for separating target substance using the same

Similar Documents

Publication Publication Date Title
US4738932A (en) Reaginic test for syphilis
US4060597A (en) Serological reagent and preparation thereof
JPS6215825B2 (en)
EP0194156B1 (en) Method of measuring the amount of immune antibody in serum
JPS6161062B2 (en)
SU1091844A3 (en) Diagnosticum for finiding agtigene of hepathitis b
EP0323692B1 (en) Water-insoluble reagent, elements containing same and methods of use
EP0101166B1 (en) Method of measuring infectious disease antibodies
JP2682697B2 (en) Immunoassay reagents and immunoassays
JPS6314911B2 (en)
US4792527A (en) Method of assaying biologically active substances and labelling agents therefor
JP2661664B2 (en) Latex agglutination method and agglutination reagent for detecting anti-streptococcus DNase B
JPH06130060A (en) Method for increasing specific gravity of particles for particle immunoassay
JPS60177265A (en) Antibody immunoglobulin class detection method
JP2000046828A (en) Immunological assay reagent and method for producing immunological assay reagent
JP3220545B2 (en) Rheumatoid factor determination method and reagent for performing the method
RU2139539C1 (en) Method of treponema antigenic diagnosticum preparing
JPH0720129A (en) Immunological agglutination reagent
JPH08327629A (en) Sample pretreatment method
JP3359415B2 (en) Method for producing immunodiagnostic agent for measuring antiphospholipid antibody
US3697639A (en) Serological test for the detection of hepatitis
JPH09502263A (en) Hydrazine-derivatized cells
JP2584924B2 (en) Method for producing immunological agglutination particles
JPH0121908B2 (en)
JPH0359382B2 (en)

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19990831